Drugs / Hexylaminolaevulinate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02149342 | May 2014 → Sep 2015 | actinic keratosis | Joint Authority for Päijät-Häme Social and Health Care | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hexylaminolaevulinate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02149342 ↗ |
| Known as | Hexyl-5-aminolaevulinate | “Hexyl-5-aminolaevulinate 0·2% vs. methyl-5-aminolaevulinate 16% daylight photodynamic therapy for treatment of actinic keratoses: results of a randomized double-blinded pilot trial.” PMID 26011755 ↗ Nov 2015 |
| Route | Topical | “Topical 0.2% Hexylaminolaevulinate With 16% Methylaminolaevulinate” NCT02149342 ↗ |